Onyx Pharmaceuticals Becomes Oversold (ONXX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Monday, shares of Onyx Pharmaceuticals, Inc. ( ONXX) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $79.11 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 34.9. A bullish investor could look at ONXX's 29.6 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ONXX shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Onyx Pharmaceuticals, Inc. 1 Year Performance Chart

Looking at the chart above, ONXX's low point in its 52 week range is $60.00 per share, with $101.57 as the 52 week high point — that compares with a last trade of $80.55.

According to the ETF Finder at ETF Channel, ONXX makes up 3.35% of the Biotech ETF ( BBH) which is trading lower by about 1% on the day Monday.
null

If you liked this article you might like

Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird

The Street Can't Help but Love Amgen

Biotech Stock Bubble Talk Deflated By Cost-Conscious Buyers

Trade-Ideas: Onyx Pharmaceuticals (ONXX) Is Today's "Water-Logged And Getting Wetter" Stock

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan